September 18, 2014 10:05 AM ET

Pharmaceuticals

Company Overview of Speciality European Pharma Limited

Company Overview

Speciality European Pharma Limited acquires, develops, and commercializes specialty therapeutic products in the European market. Its products include Haemopressin for the treatment of bleeding oesophageal varices, Plenaxis for the treatment of prostate cancer, Cortirel for in vivo diagnosis of pituitary-adrenal function, and Amphocil for the treatment of fungal infections. It also manufactures a cytotoxic medicine used in the treatment of cancers, including bladder cancer. The company markets its products through a network of distribution partners. It has commercial operations in the United Kingdom, Switzerland, France, Germany, and Italy. It was formerly known as Advent Investments Ltd. and...

16 John Street

London,  WC1N 2DL

United Kingdom

Founded in 1996

Phone:

44 20 7421 7400

Fax:

44 20 7421 7401

Key Executives for Speciality European Pharma Limited

Chief Executive Officer and Director
Founder and Non Executive Director
Vice President of Operations
Managing Director of Speciality European Pharma for Germany
Managing Director of Speciality European Pharma International AG
Compensation as of Fiscal Year 2014.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Speciality European Pharma Limited, please visit www.specialityeuropeanpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.